NYSE:CRLLife Sciences
Is Charles River (CRL) Quietly Redefining Its Edge Through Complex Biologics and Vaccine Testing?
Earlier this week, Medigen Vaccine Biologics announced it is partnering with Charles River Laboratories International to characterize and validate the virus seed bank and support Chemistry, Manufacturing, and Controls activities for Medigen’s next-generation multivalent enterovirus vaccine using advanced tools such as Next-Generation Sequencing.
The collaboration highlights Charles River’s role as a specialist in complex biologics testing and regulatory readiness, potentially strengthening...